BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

eTheRNA

eTheRNA logo

Founded
2013
Patents
1
Publications
6

eTheRNA immunotherapies' mission is to help patients to overcome certain cancers and infectious diseases by developing novel immunotherapies that target the fundamental role of dendritic cells in the human immune system. eTheRNA’s proprietary mRNA-based TriMix technology boosts dendritic cells leading to a more comprehensive, sustainable and safer enhancement of the patient’s immune system than any other similar approach investigated until now.

Get access to BPT Crunch to view additional information about this company

Posts Mentioning This Company